Search Results - "Valsami, S."

  • Showing 1 - 10 results of 10
Refine Results
  1. 1

    Effect of mirasol pathogen reduction technology system on immunomodulatory molecules of apheresis platelets by Valsami, S., Grouzi, E., Mochandreou, D., Pouliakis, A., Piroula-Godoy, M., Kokori, S., Pittaras, T., Raikou, A., Politou, M.

    Published in Transfusion and apheresis science (01-02-2023)
    “…Pathogen inactivation for platelets by riboflavin system (MIRASOL) efficiently reduces transfusion related pathogen transmission. However little is known about…”
    Get full text
    Journal Article
  2. 2

    A case of Alemtuzumab-induced neutropenia in multiple sclerosis in association with the expansion of large granular lymphocytes by Vakrakou, A G, Tzanetakos, D, Valsami, S, Grigoriou, E, Psarra, K, Tzartos, J, Anagnostouli, M, Andreadou, E, Evangelopoulos, M E, Koutsis, G, Chrysovitsanou, C, Gialafos, E, Dimitrakopoulos, A, Stefanis, L, Kilidireas, C

    Published in BMC neurology (29-10-2018)
    “…Alemtuzumab has been demonstrated to reduce the risks of relapse and accumulation of sustained disability in Multiple Sclerosis (MS) patients compared to…”
    Get full text
    Journal Article
  3. 3
  4. 4
  5. 5

    Alloimmunisation during pregnancy in Greece: need for nationwide HDFN prevention programme by Foudoulaki-Paparizos, L., Valsami, S., Bournas, N., Tsantes, A., Grapsas, P., Mantzios, G., Travlou, A., Politou, M.

    Published in Transfusion medicine (Oxford, England) (01-08-2013)
    “…SUMMARY Aim/Objectives To access the incidence and specificity of maternal red blood cells alloimmunisation and its relevant clinical impact in Greece…”
    Get full text
    Journal Article
  6. 6
  7. 7

    Monoclonal gammopathies in B-cell non-Hodgkin’s lymphomas by Economopoulos, T, Papageorgiou, S, Pappa, V, Papageorgiou, E, Valsami, S, Kalantzis, D, Xiros, N, Dervenoulas, J, Raptis, S

    Published in Leukemia research (01-06-2003)
    “…The association of monoclonal gammopathy (MG) with B-cell non-Hodgkin’s lymphomas (NHL) is a well known phenomenon. The aim of the present work was to study…”
    Get full text
    Journal Article
  8. 8
  9. 9

    Rituximab in combination with vinorelbine/gemcitabine chemotherapy in patients with primary refractory or early relapsed T cell rich B cell lymphoma: A pilot study by Xiros, Nikolaos, Economopoulos, Theofanis, Valsami, Serena, Rontogianni, Dimitra, Fountzilas, George, Raptis, Sotirios

    Published in Leukemia research (01-12-2003)
    “…Rituximab is a chimeric monoclonal antibody that binds specifically to the CD20 antigen expressed in most B cell lymphomas. As single agent or in combination…”
    Get full text
    Journal Article
  10. 10